BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

748 related articles for article (PubMed ID: 12648229)

  • 1. Afferent and efferent phases of allergic contact dermatitis (ACD) can be induced after a single skin contact with haptens: evidence using a mouse model of primary ACD.
    Saint-Mezard P; Krasteva M; Chavagnac C; Bosset S; Akiba H; Kehren J; Kanitakis J; Kaiserlian D; Nicolas JF; Berard F
    J Invest Dermatol; 2003 Apr; 120(4):641-7. PubMed ID: 12648229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of CD4+ and CD8+ T cells in contact hypersensitivity and allergic contact dermatitis.
    Saint-Mezard P; Berard F; Dubois B; Kaiserlian D; Nicolas JF
    Eur J Dermatol; 2004; 14(3):131-8. PubMed ID: 15246935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin exposure to weak and moderate contact allergens induces IFNgamma production by lymph node cells of CD4+ T-cell-depleted mice.
    Vocanson M; Hennino A; Rozières A; Cluzel-Tailhardat M; Poyet G; Valeyrie M; Bénetière J; Tédone R; Kaiserlian D; Nicolas JF
    J Invest Dermatol; 2009 May; 129(5):1185-91. PubMed ID: 19005487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergic contact dermatitis.
    Gober MD; Gaspari AA
    Curr Dir Autoimmun; 2008; 10():1-26. PubMed ID: 18460878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8+ T cells are effector cells of contact dermatitis to common skin allergens in mice.
    Vocanson M; Hennino A; Cluzel-Tailhardat M; Saint-Mezard P; Benetiere J; Chavagnac C; Berard F; Kaiserlian D; Nicolas JF
    J Invest Dermatol; 2006 Apr; 126(4):815-20. PubMed ID: 16456532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissection of antigenic and irritative effects of epicutaneously applied haptens in mice. Evidence that not the antigenic component but nonspecific proinflammatory effects of haptens determine the concentration-dependent elicitation of allergic contact dermatitis.
    Grabbe S; Steinert M; Mahnke K; Schwartz A; Luger TA; Schwarz T
    J Clin Invest; 1996 Sep; 98(5):1158-64. PubMed ID: 8787679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effector and regulatory mechanisms in allergic contact dermatitis.
    Vocanson M; Hennino A; Rozières A; Poyet G; Nicolas JF
    Allergy; 2009 Dec; 64(12):1699-714. PubMed ID: 19839974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of CD4(+ )and CD8(+) T-cells in contact hypersensitivity and allergic contact dermatitis.
    Vocanson M; Hennino A; Chavagnac C; Saint-Mezard P; Dubois B; Kaiserlian D; Nicolas JF
    Expert Rev Clin Immunol; 2005 May; 1(1):75-86. PubMed ID: 20477656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse.
    Takeshita K; Yamasaki T; Akira S; Gantner F; Bacon KB
    Int Immunol; 2004 May; 16(5):685-95. PubMed ID: 15096484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of effector CD8+ T cells in contact hypersensitivity occurs independently of CD4+ T cells.
    Xu H; Banerjee A; Dilulio NA; Fairchild RL
    J Immunol; 1997 May; 158(10):4721-8. PubMed ID: 9144485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4
    Murata A; Hayashi SI
    Front Immunol; 2020; 11():775. PubMed ID: 32508808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunology of contact dermatitis.
    Bos JD; Teunissen MB; Kapsenberg ML
    Acta Derm Venereol Suppl (Stockh); 1989; 151():84-7; discussion 106-10. PubMed ID: 2696311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathomechanisms of the elicitation phase of allergic contact dermatitis].
    Riemann H; Schwarz T; Grabbe S
    J Dtsch Dermatol Ges; 2003 Aug; 1(8):613-9. PubMed ID: 16296151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contact hypersensitivity.
    Gaspari AA; Katz SI
    Curr Protoc Immunol; 2001 May; Chapter 4():Unit 4.2. PubMed ID: 18432793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin contact irritation conditions the development and severity of allergic contact dermatitis.
    Bonneville M; Chavagnac C; Vocanson M; Rozieres A; Benetiere J; Pernet I; Denis A; Nicolas JF; Hennino A
    J Invest Dermatol; 2007 Jun; 127(6):1430-5. PubMed ID: 17273160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial recruitment of interferon-gamma-producing CD8+ effector cells, followed by infiltration of CD4+ cells in 2,4,6-trinitro-1-chlorobenzene (TNCB)-induced murine contact hypersensitivity reactions.
    Okazaki F; Kanzaki H; Fujii K; Arata J; Akiba H; Tsujii K; Iwatsuki K
    J Dermatol; 2002 Nov; 29(11):699-708. PubMed ID: 12484431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invariant NKT cells suppress CD8(+) T-cell-mediated allergic contact dermatitis independently of regulatory CD4(+) T cells.
    Goubier A; Vocanson M; Macari C; Poyet G; Herbelin A; Nicolas JF; Dubois B; Kaiserlian D
    J Invest Dermatol; 2013 Apr; 133(4):980-7. PubMed ID: 23190881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ T cells regulate CD8+ T cell-mediated cutaneous immune responses by restricting effector T cell development through a Fas ligand-dependent mechanism.
    Gorbachev AV; Fairchild RL
    J Immunol; 2004 Feb; 172(4):2286-95. PubMed ID: 14764697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vivo Expansion of Endogenous Regulatory T Cell Populations Induces Long-Term Suppression of Contact Hypersensitivity.
    El Beidaq A; Link CW; Hofmann K; Frehse B; Hartmann K; Bieber K; Martin SF; Ludwig RJ; Manz RA
    J Immunol; 2016 Sep; 197(5):1567-76. PubMed ID: 27439515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral administration of paeoniflorin attenuates allergic contact dermatitis by inhibiting dendritic cell migration and Th1 and Th17 differentiation in a mouse model.
    Shi D; Li X; Li D; Zhao Q; Shen Y; Yan H; Fu H; Zheng H; Lu G; Qiu Y; Liu W
    Int Immunopharmacol; 2015 Apr; 25(2):432-9. PubMed ID: 25744601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.